Concepedia

Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer

Karen E. Hoffman, Frankie A. Holmes, Giuseppe Fraschini, Laura Esparza, Debra Frye, Martin N. Raber, Robert A. Newman, Gabriel N. Hortobágyi

Cancer Chemotherapy and Pharmacology · 1995 · 58 citations · 10 references

DOI

Concepts

References

10

Comprehensive Criteria for Assessing Therapy-Induced Toxicity

Jaffer A. Ajani, Susan Welch, Martin N. Raber et al. · Cancer Investigation · 1990 · 240 citations

, , +17

Phase I study of tricyclic nucleoside phosphate using a five-day continuous infusion schedule.

Lynn G. Feun, Niramol Savaraj, Gerald P. Bodey et al. · PubMed · 1984 · 54 citations

, , +17

The synthesis of 6-amino-4-methyl-8-(β-D-ribofuranosyl) (4-H,8-H)pyrrolo-[4,3,2-de]pyrimido[4,5-c]pyridazine, a new tricyclic nucleoside

Karl H. Schram, Leroy B. Townsend · Tetrahedron Letters · 1971 · 47 citations

, , +8

Transport, Phosphorylation, and Toxicity of a Tricyclic Nucleoside in Cultured Novikoff Rat Hepatoma Cells and Other Cell Lines and Release of Its Monophosphate by the Cells 2

Peter G.W. Plagemann · JNCI Journal of the National Cancer Institute · 1976 · 34 citations

, , +9

Dual mechanisms of inhibition of DNA synthesis by triciribine.

Linda L. Wotring, L. B. TOWNSEND, Lois Μ. Jones et al. · PubMed · 1990 · 25 citations

, , +16